Interesting facts
Interesting Facts about N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide
N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide is a fascinating compound that showcases the complexity and beauty of organic chemistry. Here are some intriguing aspects about this compound:
- Pharmaceutical Potential: This compound belongs to a class of molecules that may possess significant therapeutic potential. Compounds like this are often evaluated for their roles in treating various neurological disorders and cognitive enhancement due to their interaction with the central nervous system.
- Structural Diversity: The compound features a quinoline ring, which is a bicyclic structure known for its presence in many natural products and synthetic drugs. Its unique structure can lead to interesting biological properties.
- Synthetic Pathways: The synthesis of this compound involves multiple steps, including cyclization and functional group modifications. This presents a great learning opportunity for students interested in synthetic organic chemistry, as they can explore various methodologies.
- Biological Activity: Preliminary studies suggest that compounds with similar structures may exhibit a range of biological activities, such as antimicrobial, anti-inflammatory, and antitumor properties. This makes them candidates for further research and drug development.
- Structure-Activity Relationship: Understanding how changes to the structure of this compound affect its biological activity could be a captivating area of study, aiding in the design of more effective pharmaceuticals.
In summary, N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide is not just a chemical entity; it is a gateway to potential groundbreaking discoveries in medicinal chemistry. As scientists explore its properties and applications, this compound exemplifies the intricate relationship between structure and function in chemical compounds.
Synonyms
cilostamide
68550-75-4
Cilostamidum
Cilostamida
Cilostamide [INN]
N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide
OPC 3689
Cilostamidum [INN-Latin]
Cilostamida [INN-Spanish]
OPC-3689
OPC 3869
N-Cyclohexyl-N-methyl-4-((2-oxo-1,2-dihydroquinolin-6-yl)oxy)butanamide
DTXSID3045140
N-Cyclohexyl-4-((1,2-dihydro-2-oxo-6-quinolyl)oxy)-N-methylbutyramide
UNII-45S5605Q18
CILOSTAMIDE [JAN]
MFCD00673958
CHEMBL34431
45S5605Q18
DTXCID1025140
N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide
N-cyclohexyl-N-methyl-4-[(2-oxo-1,2-dihydroquinolin-6-yl)oxy]butanamide
Butanamide, N-cyclohexyl-4-((1,2-dihydro-2-oxo-6-quinolinyl)oxy)-N-methyl-
NCGC00015269-03
Cilostamidum (INN-Latin)
Cilostamida (INN-Spanish)
CAS-68550-75-4
SR-01000075781
Cilostamide (OPC 3689)
Tocris-0915
Lopac-C-7971
Lopac0_000288
SCHEMBL49742
GTPL5167
BDBM15297
CHEBI:92503
EX-A7844E
UIAYVIIHMORPSJ-UHFFFAOYSA-N
HMS2090J06
HMS3260J18
HMS3267A21
HMS3411F22
HMS3675F22
HMS3742E05
6-[3-(N-Cyclohexyl-N-methylcarbamoyl)propoxy]quinolin-2[1H]-one
BCP08355
Tox21_110119
Tox21_500288
BDBM50027177
HSCI1_000142
AKOS024458692
Cilostamide - CAS 68550-75-4
Cilostamide phosphodiesterase inhibitor
Tox21_110119_1
CCG-204383
Cilostamide, phosphodiesterase inhibitor
LP00288
SB72501
SDCCGSBI-0050276.P002
NCGC00015269-01
NCGC00015269-02
NCGC00015269-04
NCGC00015269-05
NCGC00015269-06
NCGC00015269-11
NCGC00024869-01
NCGC00024869-02
NCGC00024869-03
NCGC00260973-01
AS-72168
DB-244275
HY-101312
CS-0021135
EU-0100288
NS00125673
S5806
A10802
C 7971
AB01275528-01
SR-01000075781-1
SR-01000075781-3
BRD-K28578425-001-01-3
BRD-K28578425-001-02-1
BRD-K28578425-001-03-9
BRD-K28578425-001-04-7
BRD-K28578425-001-06-2
BRD-K28578425-001-07-0
Q15634085
6-[3-(N-cyclohexyl-N-methylaminocarbonyl)propoxy]carbostyril
6-[3-(N-methyl-N-cyclohexylaminocarbonyl)propoxy]-carbostyril
6-[3-(N-methyl-N-cyclohexylaminocarbonyl)propoxy]carbostyril
N-Cyclohexyl-4-((2-hydroxyquinolin-6-yl)oxy)-N-methylbutanamide
N-cyclohexyl-4-[(1,2-dihydro-2-oxo-6-quinolinyl)oxy]-N-methyl-butanamide
N-Cyclohexyl-N-methyl-4-(2-oxo-1,2-dihydro-quinolin-6-yloxy)-butyramide
Solubility Overview of N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide
The solubility of N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide (C21H28N2O3) can significantly influence its applications in various fields, particularly in pharmaceuticals and biochemistry. This compound presents notable characteristics in its solubility profile that merit discussion.
Factors Influencing Solubility
Understanding factors that affect the solubility of this compound includes:
Solubility Predictions
While precise solubility data may be limited, we can anticipate:
In conclusion, the solubility of N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide is a complex interplay of its molecular design and the choice of solvent. Understanding these characteristics is crucial for effectively utilizing this compound in practical applications.